Published in Am J Surg Pathol on June 01, 1999
Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies. Endocr Relat Cancer (2008) 2.10
Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis. Am J Pathol (2001) 1.28
ECM1 and TMPRSS4 are diagnostic markers of malignant thyroid neoplasms and improve the accuracy of fine needle aspiration biopsy. Ann Surg (2005) 1.27
Evidence for a telomere-independent "clock" limiting RAS oncogene-driven proliferation of human thyroid epithelial cells. Mol Cell Biol (2000) 1.02
Expression of transforming growth factor-beta-1 and p27Kip1 in pancreatic adenocarcinomas: relation with cell-cycle-associated proteins and clinicopathologic characteristics. BMC Cancer (2005) 0.99
p27Kip1 is expressed in proliferating cells in its form phosphorylated on threonine 187. BMC Clin Pathol (2005) 0.98
Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma. Am J Pathol (2002) 0.95
Differential expression patterns and clinical significance of estrogen receptor-α and β in papillary thyroid carcinoma. BMC Cancer (2014) 0.87
Cyclin D1 and p27 expression as prognostic factor in papillary carcinoma of thyroid: association with clinicopathological parameters. Croat Med J (2008) 0.83
Clinical, pathologic, and immunohistochemical prognostic factors in dogs with thyroid carcinoma. J Vet Intern Med (2014) 0.82
p27 Kip1 protein expression in Hashimoto's thyroiditis. J Clin Pathol (2003) 0.81
Cell Cycle Regulatory Proteins p27(kip), Cyclins Dl and E and Proliferative Activity in Oncocytic (Hurthle Cell) Lesions of the Thyroid. Endocr Pathol (2000) 0.80
Accumulation of p27(kip1) is associated with cyclin D3 overexpression in the oxyphilic (Hurthle cell) variant of follicular thyroid carcinoma. J Clin Pathol (2006) 0.79
p27(kip1) and Other Cell-Cycle Protein Expression in Normal and Neoplastic Endocrine Tissues. Endocr Pathol (2000) 0.77
Altered expression of estrogen receptor β2 is associated with different biological markers and clinicopathological factors in papillary thyroid cancer. Int J Clin Exp Pathol (2015) 0.77
Post-surgical treatment of thyroid carcinoma in dogs with retinoic acid 9 cis improves patient outcome. Open Vet J (2016) 0.76
A Pilot Study of Galectin-3, HBME-1, and p27 Triple Immunostaining Pattern for Diagnosis of Indeterminate Thyroid Nodules in Cytology With Correlation to Histology. Appl Immunohistochem Mol Morphol (2015) 0.76
MicroRNAs in the thyroid. Best Pract Res Clin Endocrinol Metab (2016) 0.75
Managing attribute--value clinical trials data using the ACT/DB client-server database system. J Am Med Inform Assoc (1998) 7.68
Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet (1997) 6.99
Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels. Ann Oncol (2002) 4.32
Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction. Nat Genet (1999) 4.23
Regulation of nitrate reductase levels in the cyanobacteria Anacystis nidulans, Anabaena sp. strain 7119, and Nostoc sp. strain 6719. J Bacteriol (1981) 4.17
Alterations in Notch signaling in neoplastic lesions of the human cervix. Proc Natl Acad Sci U S A (1995) 3.33
Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer (1996) 3.07
Molecular mechanism for the operation of nitrogen control in cyanobacteria. EMBO J (1994) 2.99
NtcA, a global nitrogen regulator from the cyanobacterium Synechococcus that belongs to the Crp family of bacterial regulators. Mol Microbiol (1992) 2.91
Requirement of the regulatory protein NtcA for the expression of nitrogen assimilation and heterocyst development genes in the cyanobacterium Anabaena sp. PCC 7120. Mol Microbiol (1994) 2.90
Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst (1999) 2.90
Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells. Gut (2009) 2.75
bcl-2 expression in pleural and extrapleural solitary fibrous tumours. J Pathol (1997) 2.66
The microtubule-affecting drug paclitaxel has antiangiogenic activity. Clin Cancer Res (1996) 2.57
Identification and cloning of a regulatory gene for nitrogen assimilation in the cyanobacterium Synechococcus sp. strain PCC 7942. J Bacteriol (1990) 2.52
The effects of school-based health clinics in St. Paul on school-wide birthrates. Fam Plann Perspect (1993) 2.50
Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung. Am J Surg Pathol (2001) 2.42
Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer (1985) 2.31
Hydraulic adjustment of Scots pine across Europe. New Phytol (2009) 2.20
p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am J Surg Pathol (2001) 2.19
Evaluation of neuroleptic drug use by nursing home elderly under proposed Medicare and Medicaid regulations. JAMA (1991) 2.18
Patterns of integrin common chain beta 1 and collagen IV immunoreactivity in hepatocellular carcinoma. Correlations with tumour growth rate, grade and size. J Pathol (1993) 2.12
Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol (2002) 2.03
Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer. Ann Oncol (2010) 2.02
RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. Clin Cancer Res (1998) 2.00
1st International consensus guidelines for advanced breast cancer (ABC 1). Breast (2012) 1.96
Genetic analysis of benign, low-grade, and high-grade ovarian tumors. Cancer Res (1995) 1.91
Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma. Cancer Res (1999) 1.86
Oxidative damage to mitochondrial DNA is inversely related to maximum life span in the heart and brain of mammals. FASEB J (2000) 1.85
Cathepsin D in host stromal cells, but not in tumor cells, is associated with aggressive behavior in node-negative breast cancer. Hum Pathol (1996) 1.81
General distribution of the nitrogen control gene ntcA in cyanobacteria. J Bacteriol (1993) 1.71
Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement. Ann Oncol (2012) 1.69
WAG-F8(m1Ycb) rats harboring a factor VIII gene mutation provide a new animal model for hemophilia A. J Thromb Haemost (2010) 1.69
Outcome of special types of luminal breast cancer. Ann Oncol (2011) 1.67
Radio imaging of the very-high-energy gamma-ray emission region in the central engine of a radio galaxy. Science (2009) 1.66
Very-high-energy gamma rays from a distant quasar: how transparent is the universe? Science (2008) 1.65
Cancer-testis antigen expression in triple-negative breast cancer. Ann Oncol (2010) 1.65
Nitrate assimilation gene cluster from the heterocyst-forming cyanobacterium Anabaena sp. strain PCC 7120. J Bacteriol (1997) 1.63
Epithelioid angiosarcoma arising in uterine leiomyomas. Am J Clin Pathol (1993) 1.63
The hetC gene is a direct target of the NtcA transcriptional regulator in cyanobacterial heterocyst development. J Bacteriol (1999) 1.61
Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effects. Ann Oncol (2005) 1.60
Regulation of survivin expression by IGF-1/mTOR signaling. Oncogene (2006) 1.59
Radioguided sentinel lymph node biopsy in breast cancer surgery. J Nucl Med (2001) 1.57
Poorly differentiated ("insular") thyroid carcinoma. A reinterpretation of Langhans' "wuchernde Struma". Am J Surg Pathol (1984) 1.57
Nitrite reductase gene from Synechococcus sp. PCC 7942: homology between cyanobacterial and higher-plant nitrite reductases. Plant Mol Biol (1993) 1.56
Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer. Br J Cancer (2003) 1.55
Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial. Ann Oncol (2007) 1.54
Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer. J Nucl Med (1998) 1.53
Escaping the stem cell compartment: sustained UVB exposure allows p53-mutant keratinocytes to colonize adjacent epidermal proliferating units without incurring additional mutations. Proc Natl Acad Sci U S A (2001) 1.53
Calretinin: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol (1996) 1.52
The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis. Int J Cancer (1994) 1.51
Expression of E-cadherin in squamous cell carcinomas of the supraglottic larynx with correlations to clinicopathological features. Eur J Cancer (2002) 1.51
Should liver metastases of breast cancer be biopsied to improve treatment choice? Ann Oncol (2011) 1.50
Ammonium/methylammonium permeases of a Cyanobacterium. Identification and analysis of three nitrogen-regulated amt genes in synechocystis sp. PCC 6803. J Biol Chem (1998) 1.50
Pruritic and nociceptive sensations and dysesthesias from a spicule of cowhage. J Neurophysiol (2009) 1.49
Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer (1999) 1.48
Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer. Ann Oncol (2010) 1.47
Nitrogen assimilation and nitrogen control in cyanobacteria. Biochem Soc Trans (2005) 1.46
Quality indicators in breast cancer care. Eur J Cancer (2010) 1.46
Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study. Ann Oncol (2014) 1.45
The problem of the accuracy of intraoperative examination of axillary sentinel nodes in breast cancer. Ann Surg Oncol (2001) 1.45
Ovarian serous borderline tumors with lymph node involvement. Clinicopathologic and DNA content study of seven cases and review of the literature. Am J Surg Pathol (1994) 1.44
Nipple sparing mastectomy with nipple areola intraoperative radiotherapy: one thousand and one cases of a five years experience at the European institute of oncology of Milan (EIO). Breast Cancer Res Treat (2009) 1.41
Angiogenesis in colorectal tumors: microvessel quantitation in adenomas and carcinomas with clinicopathological correlations. Cancer Res (1995) 1.39
Immunoreactivity for latent membrane protein 1 of Epstein-Barr virus in nevi and melanomas is not related to the viral infection. Virchows Arch (2000) 1.39
Anaplastic thyroid carcinoma. A study of 70 cases. Am J Clin Pathol (1985) 1.39
Genetic mapping of the chromosome of the cyanobacterium, Anabaena variabilis. Proximity of the structural genes for nitrogenase and ribulose-bisphosphate carboxylase. J Biol Chem (1986) 1.37
Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1. Clin Cancer Res (1997) 1.35
Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas. J Natl Cancer Inst (1994) 1.35
Human ligands of the Notch receptor. Am J Pathol (1999) 1.32
p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma. Am J Pathol (1995) 1.32
Clustering of genes involved in nitrate assimilation in the cyanobacterium Synechococcus. Mol Gen Genet (1992) 1.31
A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases. Ann Oncol (2006) 1.29
Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis. Am J Pathol (2001) 1.28
Breast cancer metastases are molecularly distinct from their primary tumors. Oncogene (2007) 1.28
Clear cell change in primary thyroid tumors. A study of 38 cases. Am J Surg Pathol (1985) 1.26
Occult axillary lymph node metastases in "node-negative" breast carcinoma. Hum Pathol (1993) 1.25
Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue. Endocr Relat Cancer (2010) 1.25
Papillary carcinoma. Semin Diagn Pathol (1985) 1.25
Amino acid transport in taxonomically diverse cyanobacteria and identification of two genes encoding elements of a neutral amino acid permease putatively involved in recapture of leaked hydrophobic amino acids. J Bacteriol (1997) 1.25
The value of radiotherapy on metastatic internal mammary nodes in breast cancer. Results on a large series. Ann Oncol (2008) 1.23
Age-related morphologic changes in the human tympanic membrane. A light and electron microscopic study. Arch Otolaryngol Head Neck Surg (1991) 1.23
Amino acid transport systems required for diazotrophic growth in the cyanobacterium Anabaena sp. strain PCC 7120. J Bacteriol (1995) 1.22
Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma. Cancer (1999) 1.22
Comparison of radioguided excision with wire localization of occult breast lesions. Br J Surg (1999) 1.22
Pulmonary epithelial-myoepithelial tumor of unproven malignant potential: report of a case and review of the literature. Mod Pathol (2001) 1.22
Localization at complex I and mechanism of the higher free radical production of brain nonsynaptic mitochondria in the short-lived rat than in the longevous pigeon. J Bioenerg Biomembr (1998) 1.21
Activation of the Anabaena nir operon promoter requires both NtcA (CAP family) and NtcB (LysR family) transcription factors. Mol Microbiol (2000) 1.21
bcl-2 oncoprotein in colorectal hyperplastic polyps, adenomas, and adenocarcinomas. Hum Pathol (1995) 1.21
Nitrogen-regulated group 2 sigma factor from Synechocystis sp. strain PCC 6803 involved in survival under nitrogen stress. J Bacteriol (2001) 1.20
Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapse. Ann Oncol (2012) 1.19
Identification, genetic analysis and characterization of a sugar-non-specific nuclease from the cyanobacterium Anabaena sp. PCC 7120. Mol Microbiol (1992) 1.18
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study. Ann Oncol (2006) 1.18
Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapy. Ann Oncol (2007) 1.17